Skip to main content
. 2020 Mar 26;15(3):e0230779. doi: 10.1371/journal.pone.0230779

Table 1. Baseline characteristic by sampling phase.

2001–2008 2009–2011 2012–2014 2015–2016 Total
Sex
Men 306(85.7) 461(92.8) 686(93.8) 526(96.5) 1979(92.9)
Women 51(14.3) 36(7.2) 45(6.2) 19(3.5) 151(7.1)
Age at diagnosis(years)a 34(28–42) 35(28–45) 34(28–46) 34(28–47) 34(28–45)
CD4 counts (cells per μL)b 323(200–433) 329(191–441) 358(228–519) 304(162–450) 333(195–471)
Transmission risk groupc
Heterosexual 119(36) 155(32.0) 178(24.5) 115(21.3) 567(27.2)
MSM 168(50.8) 304(62.7) 534(73.5) 414(76.5) 1420(68.1)
IDU 23(6.9) 21(4.3) 13(1.8) 12(2.2) 69(3.3)
Blood transfusion 21(6.3) 4(0.8) 2(0.3) 0(0) 27(1.3)
Mother to child 0(0) 1(0.2) 0(0) 0(0) 1(0.05)
Subtype
A1 3(0.8) 4(0.8) 5(0.7) 2(0.4) 14(0.7)
B 151(42.3) 119(23.9) 111(15.2) 69(12.7) 450(21.1)
C 9(2.5) 5(1) 7(1) 1(0.2) 22(1)
F1 1(0.3) 0(0) 0(0) 0(0) 1(0)
G 3(0.8) 1(0.2) 0(0) 0(0) 4(0.2)
01_AE 119(33.3) 230(46.3) 378(51.7) 277(50.8) 1004(47.1)
02_AG 0(0) 0(0) 3(0.4) 1(0.2) 4(0.2)
06_cpx 3(0.8) 0(0) 0(0) 0(0) 3(0.1)
07_BC 56(15.7) 123(24.7) 172(23.5) 140(25.7) 491(23.1)
08_BC 7(2.0) 4(0.8) 2(0.3) 3(0.6) 16(0.8)
55_01B 0(0) 3(0.6) 7(1) 3(0.6) 13(0.6)
57_BC 1(0.3) 0(0) 0(0) 0(0) 1(0)
59_01B 0(0) 0(0) 2(0.3) 2(0.4) 4(0.2)
63_02A1 0(0) 1(0.2) 0(0) 0(0) 1(0)
65_cpx 1(0.3) 1(0.2) 4(0.5) 6(1.1) 12(0.6)
67_01B 0(0) 1(0.2) 1(0.1) 0(0) 2(0.1)
68_01B 0(0) 0(0) 2(0.3) 2(0.4) 4(0.2)
URFs 3(0.8) 5(1) 37(5.1) 39(7.2) 84(3.9)
Ethnicity
Han 334(93.6) 472(95.0) 705(96.4) 538(98.7) 2049(96.2)
Minority 23(6.4) 25(5.0) 26(3.6) 7(1.3) 81(3.8)

Data are n (%) or median (IQR).

MSM = Men who have sex with men.

IDU = Injecting drug user

aData for n = 2,125.

bData for n = 1,858.

cData for n = 2,084.

URFs = Unique Recombinant Forms